Selected research
Industry Growth & Trends
Global Digital Therapeutics (DTx) For Mental Health Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Digital Therapeutics (DTx) For Mental Health market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Digital Therapeutics (DTx) For Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Digital Therapeutics (DTx) For Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Digital Therapeutics (DTx) For Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Digital Therapeutics (DTx) For Mental Health market include WellDoc, Pear Therapeutics, COGNIFIT, Ginger, Propeller Health, 2morrow, Canary Health, Noom and Teladoc Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Digital Therapeutics (DTx) For Mental Health market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Digital Therapeutics (DTx) For Mental Health market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Digital Therapeutics (DTx) For Mental Health market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Digital Therapeutics (DTx) For Mental Health.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Digital Therapeutics (DTx) For Mental Health market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Digital Therapeutics (DTx) For Mental Health Market by Company
WellDoc
Pear Therapeutics
COGNIFIT
Ginger
Propeller Health
2morrow
Canary Health
Noom
Teladoc Health
Omada Health
Digital Therapeutics (DTx) For Mental Health Segment by Type
Biology Modifying Drugs
Gene Therapies
Cell Therapies
Digital Therapeutics (DTx) For Mental Health Segment by Application
Pharmaceutical Companies
Academic and Research Institutions
Others
Digital Therapeutics (DTx) For Mental Health Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Therapeutics (DTx) For Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Therapeutics (DTx) For Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Therapeutics (DTx) For Mental Health.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Digital Therapeutics (DTx) For Mental Health companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Biology Modifying Drugs
- Gene Therapies
- Cell Therapies
Applications
- Pharmaceutical Companies
- Academic and Research Institutions
- Others
Companies covered
- WellDoc
- Pear Therapeutics
- COGNIFIT
- Ginger
- Propeller Health
- 2morrow
- Canary Health
- Noom
- Teladoc Health
- Omada Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Digital Therapeutics (DTx) For Mental Health Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Digital Therapeutics (DTx) For Mental Health Market Size by Region (2021-2032)
- 1.4.1 Global Digital Therapeutics (DTx) For Mental Health Market Size by Region (2021-2026)
- 1.4.2 Global Digital Therapeutics (DTx) For Mental Health Market Size by Region (2027-2032)
- 1.5 Key Regions Digital Therapeutics (DTx) For Mental Health Market Size (2021-2032)
- 1.5.1 North America Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate (2021-2032)
- 1.5.4 South America Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate (2021-2032)
2 Digital Therapeutics (DTx) For Mental Health Market by Type
- 2.1 Type Introduction
- 2.1.1 Biology Modifying Drugs
- 2.1.2 Gene Therapies
- 2.1.3 Cell Therapies
- 2.2 Global Digital Therapeutics (DTx) For Mental Health Market Size by Type
- 2.2.1 Global Digital Therapeutics (DTx) For Mental Health Market Size Overview by Type (2021-2032)
- 2.2.2 Global Digital Therapeutics (DTx) For Mental Health Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Digital Therapeutics (DTx) For Mental Health Market Size Forecasted by Type (2027-2032)
- 2.3 Global Digital Therapeutics (DTx) For Mental Health Market Size by Regions
- 2.3.1 North America Digital Therapeutics (DTx) For Mental Health Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Digital Therapeutics (DTx) For Mental Health Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Digital Therapeutics (DTx) For Mental Health Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Digital Therapeutics (DTx) For Mental Health Market Size Breakdown by Type (2021-2026)
3 Digital Therapeutics (DTx) For Mental Health Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Companies
- 3.1.2 Academic and Research Institutions
- 3.1.3 Others
- 3.2 Global Digital Therapeutics (DTx) For Mental Health Market Size by Application
- 3.2.1 Global Digital Therapeutics (DTx) For Mental Health Market Size Overview by Application (2021-2032)
- 3.2.2 Global Digital Therapeutics (DTx) For Mental Health Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Digital Therapeutics (DTx) For Mental Health Market Size Forecasted by Application (2027-2032)
- 3.3 Global Digital Therapeutics (DTx) For Mental Health Market Size by Regions
- 3.3.1 North America Digital Therapeutics (DTx) For Mental Health Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Digital Therapeutics (DTx) For Mental Health Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Digital Therapeutics (DTx) For Mental Health Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Digital Therapeutics (DTx) For Mental Health Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Digital Therapeutics (DTx) For Mental Health Industry Trends
- 4.2 Digital Therapeutics (DTx) For Mental Health Industry Drivers
- 4.3 Digital Therapeutics (DTx) For Mental Health Industry Opportunities and Challenges
- 4.4 Digital Therapeutics (DTx) For Mental Health Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Digital Therapeutics (DTx) For Mental Health Revenue (2021-2026)
- 5.2 Global Digital Therapeutics (DTx) For Mental Health Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Digital Therapeutics (DTx) For Mental Health Key Company Headquarters & Area Served
- 5.4 Global Digital Therapeutics (DTx) For Mental Health Company, Product Type & Application
- 5.5 Global Digital Therapeutics (DTx) For Mental Health Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Digital Therapeutics (DTx) For Mental Health Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Digital Therapeutics (DTx) For Mental Health Players Market Share by Revenue in 2025
- 5.6.3 2025 Digital Therapeutics (DTx) For Mental Health Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 WellDoc
- 6.1.1 WellDoc Company Information
- 6.1.2 WellDoc Business Overview
- 6.1.3 WellDoc Digital Therapeutics (DTx) For Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 WellDoc Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 6.1.5 WellDoc Recent Developments
- 6.2 Pear Therapeutics
- 6.2.1 Pear Therapeutics Company Information
- 6.2.2 Pear Therapeutics Business Overview
- 6.2.3 Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 6.2.5 Pear Therapeutics Recent Developments
- 6.3 COGNIFIT
- 6.3.1 COGNIFIT Company Information
- 6.3.2 COGNIFIT Business Overview
- 6.3.3 COGNIFIT Digital Therapeutics (DTx) For Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 COGNIFIT Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 6.3.5 COGNIFIT Recent Developments
- 6.4 Ginger
- 6.4.1 Ginger Company Information
- 6.4.2 Ginger Business Overview
- 6.4.3 Ginger Digital Therapeutics (DTx) For Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Ginger Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 6.4.5 Ginger Recent Developments
- 6.5 Propeller Health
- 6.5.1 Propeller Health Company Information
- 6.5.2 Propeller Health Business Overview
- 6.5.3 Propeller Health Digital Therapeutics (DTx) For Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Propeller Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 6.5.5 Propeller Health Recent Developments
- 6.6 2morrow
- 6.6.1 2morrow Company Information
- 6.6.2 2morrow Business Overview
- 6.6.3 2morrow Digital Therapeutics (DTx) For Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 2morrow Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 6.6.5 2morrow Recent Developments
- 6.7 Canary Health
- 6.7.1 Canary Health Company Information
- 6.7.2 Canary Health Business Overview
- 6.7.3 Canary Health Digital Therapeutics (DTx) For Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Canary Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 6.7.5 Canary Health Recent Developments
- 6.8 Noom
- 6.8.1 Noom Company Information
- 6.8.2 Noom Business Overview
- 6.8.3 Noom Digital Therapeutics (DTx) For Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Noom Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 6.8.5 Noom Recent Developments
- 6.9 Teladoc Health
- 6.9.1 Teladoc Health Company Information
- 6.9.2 Teladoc Health Business Overview
- 6.9.3 Teladoc Health Digital Therapeutics (DTx) For Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Teladoc Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 6.9.5 Teladoc Health Recent Developments
- 6.10 Omada Health
- 6.10.1 Omada Health Company Information
- 6.10.2 Omada Health Business Overview
- 6.10.3 Omada Health Digital Therapeutics (DTx) For Mental Health Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Omada Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 6.10.5 Omada Health Recent Developments
7 North America
- 7.1 North America Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Digital Therapeutics (DTx) For Mental Health Market Size by Country (2021-2026)
- 7.3 North America Digital Therapeutics (DTx) For Mental Health Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Digital Therapeutics (DTx) For Mental Health Market Size by Country (2021-2026)
- 8.3 Europe Digital Therapeutics (DTx) For Mental Health Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Digital Therapeutics (DTx) For Mental Health Market Size by Country (2021-2026)
- 10.3 South America Digital Therapeutics (DTx) For Mental Health Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst